PLUS THERAPEUTICS FILES 8-K: AGREEMENT & EQUITY SALES
Ticker: PSTV · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, corporate-filing
TL;DR
PLUS THERAPEUTICS (PSTX) filed an 8-K on March 4, 2025, reporting a material definitive agreement and unregistered equity sales.
AI Summary
On March 4, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report detailing a material definitive agreement and unregistered sales of equity securities. The company, formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC, is incorporated in Delaware and headquartered in Austin, Texas.
Why It Matters
This filing indicates significant corporate activity, including new agreements and the issuance of equity, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can carry inherent risks related to deal terms and dilution.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- CYTORI THERAPEUTICS, INC. (company) — Former Company Name
- MACROPORE INC (company) — Former Company Name
- March 4, 2025 (date) — Date of Report
FAQ
What type of material definitive agreement was entered into by PLUS THERAPEUTICS, INC.?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
What was the former name of PLUS THERAPEUTICS, INC.?
PLUS THERAPEUTICS, INC. was formerly known as CYTORI THERAPEUTICS, INC. and prior to that, MACROPORE INC.
When was this 8-K report filed?
This 8-K report was filed on March 4, 2025.
Where is PLUS THERAPEUTICS, INC. headquartered?
PLUS THERAPEUTICS, INC. is headquartered at 4200 Marathon Blvd., Suite 200, Austin, Texas 78756.
What other items are reported in this 8-K filing besides the material definitive agreement?
In addition to the material definitive agreement, the filing also reports on unregistered sales of equity securities and includes financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).